Table 1 Characteristics of healthy controls and patients with BD
From: MicroRNAs differentially expressed in Behçet disease are involved in interleukin-6 production
Demographics | Controls (n = 8) | Stable BD (n = 10) | Active BD (n = 11) |
|---|---|---|---|
Age (mean age ± SD) | 29.3 ± 4.5 | 43.2 ± 11.0 | 44.8 ± 4.3 |
Sex (male : female) | 4:4 | 7:3 | 5:6 |
Clinical features of BD patients | Case No (%) | ||
Oral ulcer | 1 (9.1) | ||
Erythema nodosum | 6 (54.5) | ||
Ocular symptoms | 4 (36.4) | ||
Arthralgia | 1 (9.1) | ||
Gastrointestinal involvement | 1 (9.1) | ||
Neurological involvement | 1 (9.1) | ||
HLA-B51 | 5 (50) | 6 (54.5) | |
Medication | |||
Immunosuppressive agentsa | 2 (20) | 7 (63.7) | |
Colchicine | 10 (100) | 10 (90.9) | |
other antiinflammatory agentsb | 9 (90) | 10 (90.9) | |
Minocycline | 1 (10) | 5 (45.5) | |